EGFR and non-small cell lung carcinoma: Polymeric nanoparticles are employed in both gene therapy and chemotherapy for non-small-cell lung cancer (NSCLC) through active receptor-mediated targeting, via receptors such as the epidermal growth factor receptor (EGFR), transferrin, or integrins, as well as passive targeting via the enhanced permeability and retention (EPR) effect.